WallStreetZenWallStreetZen

NASDAQ: OCX
Oncocyte Corp Earnings & Revenue

OCX earnings and revenue history

Current Revenue
-$2.4M
Current Earnings
-$58.1M
Current Profit Margin
2,462.4%

OCX Return on Equity

Current Company
-151.6%
Current Industry
-50%
Current Market
-8.4%
OCX's Return on Equity (-151.6%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when OCX announces earnings.

OCX Return on Assets

Current Company
-66.1%
Current Industry
6.8%
OCX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

OCX Return on Capital Employed

Current Company
-78.17%
Current Industry
10.9%
OCX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

OCX vs Diagnostic & Research Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
OCX-$2.36M-$54.87M-$58.14MN/AN/A
DMTK$15.30M-$95.04M-$100.89M+44.33%N/A
XGN$52.55M-$18.21M-$23.69M+10.13%N/A
CNTG$55.12M-$44.39M-$61.44M+1.95%N/A
BIAF$321.49k-$7.04M-$7.24M+12,989.94%N/A

OCX earnings dates

Next earnings date
May 9, 2024

Oncocyte Earnings & Revenue FAQ

What were OCX's earnings last quarter?

On Invalid Date, Oncocyte (NASDAQ: OCX) reported Q3 2023 earnings per share (EPS) of -$0.81, up 50% year over year. Total Oncocyte earnings for the quarter were -$6.69 million. In the same quarter last year, Oncocyte's earnings per share (EPS) was -$1.62.

If you're new to stock investing, here's how to buy Oncocyte stock.

What was OCX's earnings growth in the past year?

As of Q1 2024, Oncocyte's earnings has grown year over year. Oncocyte's earnings in the past year totalled -$58.14 million.

What is OCX's earnings date?

Oncocyte's earnings date is Invalid Date. Add OCX to your watchlist to be reminded of OCX's next earnings announcement.

What was OCX's revenue last quarter?

On Invalid Date, Oncocyte (NASDAQ: OCX) reported Q3 2023 revenue of $429.00 thousand up 540.3% year over year. In the same quarter last year, Oncocyte's revenue was $67.00 thousand.

What was OCX's revenue growth in the past year?

As of Q1 2024, Oncocyte's revenue has grown null year over year. Oncocyte's revenue in the past year totalled -$2.36 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.